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Background: Multi-transgenic pigs produced for use in xenotransplantation have to be screened for 
the presence and expression of porcine endogenous retroviruses (PERV) to select animals with low 
PERV load. The production of transgenic pigs may also be associated with the integration of the 
transgene adjacent to or into the locus of a PERV provirus, potentially leading to an enhanced virus 
expression. 
 
Methods: Non-transgenic animals, single-transgenic, and multitransgenic pigs were screened for the 
presence of PERV-A, -B, and –C and recombinant PERV-A/C using polymerase chain reaction (PCR). 
PERV expression was determined by real time reverse transcriptase-PCR. An assay based on the 
activation of PERV in peripheral blood mononuclear cells by mitogens was used to discriminate 
between low and high PERV producer animals. 
 
Results: All animals carried PERV-A and -B. A total of 176 from 181 (97.2%) animals carried PERV-C 
in the germ line and 18 from 64 animals carried PERV-A/C in the genome of lymphoid cells but not in 
the germ line. The expression of PERV was very low in all animals and not different between 
transgenic pigs and non-transgenic animals. PERV expression differed between various pig lines. The 
highest expression was found in mini-pigs and crossing other pig lines with mini-pigs resulted in 
increased PERV expression in the progeny. However, expression of viral proteins and particle release 
were not observed in all transgenic animals. 
 
Conclusions: No evidence for elevated PERV expression in (multi-) transgenic pigs was observed. 
Differences in PERV expression correlated with the genetic background of the animals, not with the 
specific transgene. Mini-pigs consistently had the highest level of PERV expression and animals with a 
























Xenotransplantation of cells, tissues, and organs from pigs to human patients is a promising solution 
for the acute shortage of human organs in allotransplantation. For several reasons, pigs are the most 
favored donor animals for xenotransplants [1]. However, there are three major obstacles to successful 
xenotransplantation: first, the immunological rejection, second, the physiological incompatibility, and 
third, the risk of zoonoses [2]. Among pig microorganisms that may be transmitted and are currently 
known to induce zoonoses, porcine endogenous retroviruses (PERV) are thought to represent the 
highest risk for human recipients [3]. PERVs are present in the genome of all pigs [4–6] and are 
released from normal pig cells [7–9], and at least PERV-A, PERV-B, and recombinants between 
PERV-A and PERV-C (PERV-A/C) have been shown to replicate in human cells in vitro, while PERV-
C is restricted to porcine cells [4,5,10–12]. In order to minimize or avoid transmission of PERV, pigs 
designed for use in xenotransplantation have to be screened for the presence of proviruses as well as 
for expression of PERV. We have developed an assay that is based on the ability of mitogens to 
increase PERV expression in peripheral blood mononuclear cells (PBMCs) [8,9]. The use of this assay 
revealed differences in the expression and release of PERV depending on the pig breed. Differences 
in PERV expression were also observed between animals of the same breed [8,9].  
 
Recently, recombinant PERV-A/Cs were discovered and de novo integrated proviruses of such 
recombinants were found in spleen cells of miniature pigs and melanoma bearing Munich miniature 
pigs [10,13–16], but not in the germ line of these animals. PERV-A/Cs represent a special risk for 
xenotransplantation because these recombinant viruses may infect human cells and increase their 
replication competence when passaged on human cells [10,17,18]. The increased titer during passage 
on human cells was associated with genetic alterations in the PERV-C-derived long terminal repeats 
of these viruses, increasing the number of nuclear factor-Y transcription factor binding sites [17]. When 
comparing the replication rate of PERV-A with that of PERV-A/C, replication rate of PERV-A/C was 
increased and an isoleucine to valine substitution was found at position 140 in the receptor binding 
domain. Changes in the proline rich region of the envelope protein were also reported [19]. The higher 
replication capacity of recombinant PERV-A/C may be associated with a higher pathogenicity as it was 
shown in the case of other retroviruses, e.g., human immunodeficiency virus (HIV) and feline leukemia 
virus.  
 
Until now, several transgenic pig lines have been produced that express immunomodulatory genes 
which suppress the hyperacute rejection (HAR) of transplanted porcine tissues and cells (for review 
see [1]). Usually integration of the foreign gene occurs at random and integration may rarely occur 
upstream of oncogenes, tumor suppressor genes, and/or proviruses of endogenous retroviruses with 
the potential for tumor development and/or enhanced expression of endogenous retroviruses. The 
goal of the present study was to evaluate the presence of PERV variants in pigs carrying one or more 
transgenes 
in comparison with wild-type animals. To reveal whether PERVs are activated in transgenic and multi-
transgenic pigs, the expression of PERVs in such animals was compared with the level of PERV 
expression in non-transgenic animals. We also show the genetic distribution of PERV-C and 
recombinant PERV-A/C in different pig breeds including wild boars. A stringent screening for PERV-C 
was performed as the presence of PERV-C in the porcine genome allows recombination with PERV-A 








Blood and tissue samples from female and male nontransgenic pigs including German Landrace (GL), 
Duroc (Du), Schwäbisch-Hällisch (SH), German Large White (GLW, Deutsches Edelschwein), Mini-pig 
(MP) as well as transgenic crossbreds (GL/Du, GL/Pietrain, Du/MP, GLW/Du/MP, GL/Du/MP) were 
obtained from the large animal facilities of the Chair for Molecular Animal Breeding and Biotechnology, 
LMU Munich, and from the Institute of Farm Animal Genetics (FLI), Mariensee. Transgenic pigs were 
produced by pronuclear DNA microinjection, by lentiviral vectors, or by somatic nuclear transfer 
(SCNT) from transfected cells pronuclear (Table 1). For production of transgenic pigs using pronuclear 
DNA microinjection or lentiviral vectors, fertilized oocytes (zygotes) were obtained by flushing the 
oviducts of estrus-synchronized and superovulated gilts that had been inseminated 24 and 36 h prior 
  
to slaughter. Embryos were collected and either centrifuged and DNA-microinjected into pronuclei 
(DNA microinjection) [20] or a lentiviral vector carrying the transgene was injected directly under 
the zona pellucida (lentiviral transgenesis) [21]. On the same day, embryo transfer was performed 
endoscopically into the oviduct of estrus synchronized recipient gilts, according to the method 
described by Besenfelder et al. [22]. Transgenic animal production by SCNT was performed as 
described recently [23]. In addition, 18 wild boars were hunted at different places near Berlin in 2005 
and were included in the analysis.  
 
 
Isolation and mitogen stimulation of porcine PBMCs  
 
Peripheral blood mononuclear cells were isolated from heparin-treated blood by density gradient 
separation using Ficoll (PAA Laboratories GmbH, Pasching, Austria). The PBMCs were isolated, 
washed three times with phosphate-buffered saline, and resuspended in RPMI-1640 medium 
(Invitrogen, Karlsruhe, Germany) with 10% fetal calf serum (lot 0898K; Biochrom, Berlin, Germany); 
106 cells per well of a 24-well plate were stimulated with 80 lg/ml phytohemagglutinin (PHA) (Oxoid, 
Wesel, Germany) for 5 days at 37 _C. Control cells were incubated in RPMI culture medium alone. 




Porcine endogenous retroviruses-producing porcine kidney cell line PK-15 and the human PERV-A/ C-
infected cell line 293/50 were obtained and cultured as described [17]. 
 
 
Determination of reverse transcriptase activity 
 
Supernatants of non-stimulated and PHA-stimulated porcine PBMCs were collected after 5 days of 
incubation and stored at )80 _C. Reverse transcriptase (RT) activity was determined using the C-type 





TotalRNAwas isolated from whole blood using the TRI-Reagent_ (Sigma, Taufkirchen, Germany) 
(0.75 ml per 0.25 ml blood). For isolation of total RNA from tissues, samples were homogenized in 
liquid nitrogen and resuspended in TRI-Reagent_ (Sigma, 1 ml per 50 to 100 mg of tissue). 
Chloroform (0.2 ml) was added and after centrifugation (12 000 g, 15 min, 4 _C) total RNA was 
purified from the aqueous phase using the RNeasy kit (Qiagen, Hilden, Germany), including an on-
column DNase digestion. For isolation of total RNA from cell cultures, 106 cells were lysed in 650 ll 
RLT_ (Qiagen) buffer of the RNeasy kit and processed following the manufacturer’s instructions. 
RNA was stored at )80 _C until assayed. 
 
 
Isolation of DNA from ear biopsies, spleen tissues, whole blood, and PBMCs 
 
DNA was isolated from ear biopsies using a salt chloroform extraction method. Sixty milligram tissue 
was incubated in 500 ll lysis buffer (160 mm saccharose, 80 mm EDTA, 100 mm Tris-HCl pH 8.0) 
(Roth, Karlsruhe, Germany) and 20 ll of a proteinase K solution (20 mg/ml, Invitrogen) at 60 _C over 
night. After addition of 200 ll of a 4.5 m NaCl solution and 700 ll chloroform/isoamyl alcohol, DNA 
extraction was performed by centrifugation (10 min, 10 000 g, 4 _C). The aqueous phase containing 
genomic DNA was mixed with 700 ll isopropanol and after centrifugation and washing with 70% (v/v) 
ethanol, the precipitated DNA was resuspended in 70 ll H2O and stored at )20 _C until assayed. DNA 
isolation from whole blood or PBMCs was performed using TRI-Reagent BD and TRIReagent, 
respectively, according to the manufacturer’s instructions (Sigma, 0.75 ml per 0.25 ml blood or 1 ml 










Provirus integration was analyzed by PCR, using primers specific for env of all three subtypes, PERV-
A, -B [24], and PERV-C [5]. For each reaction 100 ng DNA was used. Temperature conditions were as 
follows: 94 _C, 15 min; 34 cycles (94 _C, 30 s; annealing temperature, 30 s; 72 _C, 1 min); 72 _C, 5 
min. In addition to the PERVC- specific primers (envCfor, envCrev) [5], a new primer pair was 
designed and applied (envC.2for, envC.2rev). The presence of PERV-A/C recombinants was 
investigated by PCR using the following primers: PERV-A env variable region B [13], forward (VRBF) 
and two different PERV-C primers, transmembrane region (TMR) [13] and PERV-C rev [15]. PCR 
reactions were performed as described above and with the following temperature conditions: 95 _C, 
10 min; 40 cycles (95 _C, 30 s; 55 _C, 30 s; 72 _C, 2 min); 72 _C, 10 min. 
 
 
PERV-C specific real time PCR 
 
Porcine endogenous retroviruses-C specific real time PCR was performed using the MX4000 
thermocycler (Stratagene, La Jolla, CA, USA), a 5¢-hexachloro-fluorescein phosphoramidite (HEX)- 
labeled probe and primers specific for PERV-C (Table 2). 
 
 
PERV-specific real time RT-PCR 
 
Quantitative real time one-step RT-PCR was performed using the Invitrogen SuperScript III platinium 
system and the MX4000 thermocycler (Stratagene), a 6-carboxy-fluorescein (FAM)-labeled probe 
(Sigma) and primers specific for PERV gag (Table 2). PERV expression was normalized to the amount 
of total RNA as well as to the expression of the house-keeping genes, glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), b-actin, and hypoxanthine-guanine phosphoribosyltransferase (HPRT). A 
HEX-labeled probe and primers specific for porcine GAPDH as well as a FAM-labeled probe and 
primers specific for porcine HPRT (Table 2) were used [25]. For each reaction, 50 ng total RNA and 
the following temperature conditions were used: 50 _C, 15 min; 95 _C, 2 min; 45 cycles (95 _C, 15 s; 
54 _C, 30 s). Expression was normalized to total RNA, porcine GAPDH, and porcine HPRT, 
respectively, and related to expression in the PERV-producing porcine kidney cell line, PK-15, and in 
the human PERV-A/C-infected cell line 293/50. Data were analyzed using the DDCT-method [26]. 
Integrity of RNA was determined by amplifying GAPDH by one-step RT-PCR. False-positive results 





Genetic distribution of PERV in different pig breeds 
 
Atotal of 181 pigs of different breeds, including GL, Duroc (Du), SH, GLW (Deutsches Edelschwein), 
MP as well as crossbreds thereof (GL/Du, GL/ Pietrain, Du/MP, GLW/Du/MP, and GL/Du/MP) were 
analyzed using primers allowing the discrimination between the PERV subtypes A, B, and C. PERV-A 
and PERV-B proviruses were found in the genome of all animals, only five animals were negative for 
PERV-C provirus integration. These animals were GL, GL/Pietrain, and Large White (LW)/MP/Du/GL. 
To exclude false-negative results due to mutations in the primer binding sites, a second primer pair 
specific for PERV-C was designed (see Materials and methods). Using both primer pairs identical 
results were obtained. The DNAwas isolated from different sources, such as ear biopsies, whole blood 
or PBMCs (Table 3). Among the pigs tested were 85 non-transgenic animals. Only one non-transgenic 
GL animal was PERV-C-negative. Analysis included also 96 transgenic or multitransgenic pigs with 
different genetic backgrounds. Only four of these were PERV-C-negative, all four had a GL 
background. All 18 wild boars carried PERV-C proviruses (Table 4). An earlier report had shown 
absence of PERV-C in a wild boar [27]. There was no correlation between age, weight, or habitat 
on one hand and PERV-C positivity on the other. 
 
 
Detection of PERV-A/C in different pig breeds 
 
Two primer pairs were used to detect recombinant PERV-A/C proviruses. In 18 of 164 investigated 
animals, PERV-A/C was found in DNA derived from PBMCs, but not when tested in parallel in the 
  
DNA derived from ear biopsies (Table 5), indicating that the recombinant provirus in the PBMCs 
represents a de novo integration of a recombinant virus, not yet present in the germ line. As expected, 
PERV-A/C was not found in PERV-C free animals. 
 
 
PERV expression in transgenic and non-transgenic pigs 
 
To study expression of PERV in non-transgenic, transgenic, and multi-transgenic pigs, a PERVspecific 
one-step RT real time PCR assay was developed allowing to quantify expression of viral full length 
mRNA. This assay measures quantitatively, expression of PERV-A, PERV-B, and PERV-C. RNA was 
isolated from whole blood or PBMCs of non-transgenic pigs of the following genetic backgrounds: GL, 
Du, SH, German white large (GWL), MP as well as Du/GL. Expression of PERV was also studied in 
PBMCs of transgenic pigs with different hybrid background (MP/Du/ GL, GLW/MP/Du/GL, and 
GLW/MP/Du) generated by microinjection or lentiviral vectors. 
 
 
PERV expression was normalized to the amount 
 
of total RNA and compared with PERV expression in the PERV-producing porcine kidney cell line, PK-
15, or in the human cell line 293 infected with PERV/50. The level of PERV expression was also 
normalized to the level of expression of the house-keeping genes, GAPDH and HPRT. PERV 
expression in PBMCs varied slightly when different pigs of different origins were compared (Table 6). 
However, there were also differences in PERV expression, when animals of the same litter were 
compared. Despite subtle differences, PERV expression in primary PBMCs from GL, Du, SH, GWL as 
well as Du/GL was very low when compared with PERV expression in the cell lines PK-15 (lower than 
2% of the expression in these cells). The highest expression was found in a nontransgenic MP (up to 
10% of the expression of PERV in PK-15 cells). 
 
 
PERV expression in different organs of the same animal 
 
Different organs (brain, heart, lung, liver, spleen, kidney, muscle, and pancreas) from three transgenic 
animals (GL and GL/MP) as well as five nontransgenic GL animals were analyzed to determine organ-
specific differences in PERV expression (Fig. 1). Integrity of isolated RNA was confirmed PERV 
expression in mitogen-treated PBMCs Expression of porcine endogenous retroviruses was measured 
both in non-stimulated as well as PHAstimulated PBMCs in 32 transgenic and nontransgenic 
pigs (Table 7). Previous studies had shown that mitogen stimulation increases the level of PERV 
expression and that this assay discriminates between PERV low and high producers [8,9]. The highest 
expression was observed in mitogenstimulated PBMCs isolated from non-transgenic MP (93% of the 
expression of PERV in PK-15 cells). All non-transgenic LW animals showed only low level expression 
after mitogen stimulation (5%) and were classified as low producer animals. In contrast, expression of 
PERV in MP/Du/GL and LW/MP/Du animals, transgenic for TNFrelated apoptosis inducing ligand 
(TRAIL), human decay accelerating factor (hDAF), human leukocyte antigen-E (HLA-E), CD46 and 
combinations of these transgenes was in the range of 1% to 8% of the expression of PERV in PK-15 
cells in the case of non-stimulated, and of 1% to 43% in the case of stimulated PBMCs. Noteworthy is 
that these animals had some genetic background of MPs (Table 7). There was no correlation between 
PERV expression and the presence of PERV-A/C proviruses in these animals, the animals with the 
highest expression of PERV did not carry PERVA/ C (Table 7). 
 
 
Absence of virus release 
 
As PERV expression at the RNA level reached only a small proportion of the expression ofPERVin 
PK- 15 and 293/50 cells, which release PERV particles, the question arose, whether viral proteins are 
expressed and whether virus particles were released from these pigs. Different attempts to detect 
PERV proteins in normal pig tissues have failed so far. The release of particles was observed only in 
some mitogen-stimulated PBMCs using a RT activity assay (Table 7). PBMCs from animals #32 
(1.72 ± 0.11 mU/ml), #34 (2.76 ± 0.16 mU/ml), and #28 (0.75 ± 0.05 mU/ml, a minipig) released RT 
activity into the supernatant after stimulation with PHA. No virus release was observed with 
nonstimulated PBMCs and in most mitogen-stimulated PBMCs. In contrast, RT activities of 12.89 ± 
0.20 mU/ml and 26.12±0.21 mU/ml, respectively, were found in the supernatant of the cell lines PK-15 




Here, we screened a large number of transgenic pigs produced for pre-clinical xenotransplantation 
research for PERV prevalence and expression. Such careful analyses of animals are required to 
select only pigs with low or no PERV release to minimize the risk of PERV transmission to the patient. 
PERV are thought to be an important risk factor when porcine cells, tissues, or organs will be 
transplanted to human recipients, as PERV-A and PERV-B are present in the genome of all pigs and 
can infect human cells in vitro [28]. Trans-species transmission of retroviruses is a common 
phenomenon and was reported for HIV-1, resulting in the pandemic, devastating acquired 
immunodeficiency syndrome, and retroviruses closely related to PERV [for review see [29]. 
Importantly, PERV-C is not present in all pigs, thus allowing select PERV-C negative animals. 
Although PERV-C does not infect human cells, it may represent a risk factor due to putative 
recombinations between PERV-A and PERV-C. PERV-A/C are humantropic and can adapted to high 
titers when passaged on human cells in vitro [17,18]. As shown in this study, the number of PERV-C-
negative animals was low, but by selection or backcrossing, PERV-C free animals could be generated. 
The number of PERV-C integrants in existing transgenic pig lines is an important issue that needs to 
be addressed in future studies. Recombinant PERV-A/C have been observed in DNA of cells from 
lymphoid tissues of several animals; however, there is clear evidence, that these recombinant viruses 
were not present in the germ line [16].  
 
Differences in PERV expression correlated with the genetic background of the animals, not with the 
specific transgene (Tables 6 and 7). MPs had consistently the highest level of PERV expression, and 
animals with a MP background had a higher level of expression compared with animals without MP 
background. Theoretically, integration of a transgene in the vicinity of a provirus, an oncogene, a 
tumor suppressor gene, or any other gene may change the expression of these genes. This may result 
in a higher expression of PERV in tumor development or dead-born 
animals, respectively. The present study included only healthy animals and an elevated PERV 
expression was not observed in transgenic animals compared with the corresponding nontransgenic 
animals.  
 
Wild boars were included in this study because a previous report had demonstrated the lack of PERV-
C and a lower number of proviruses when compared with domestic pigs [27]. In the present 
study, all wild animals carried PERV-C, irrespective of age and the spot. Hunted in places very close 
to Berlin, these animals may have acquired the virus by contact with breeding animals. As only spleen 
tissue was investigated, but no other sample, it remains unclear whether PERV-C in these animals is 
endogenous or exogenous.  
 
Our results confirm previous reports on differences in the expression between different pig breeds as 
well as between animals within a particular breed [8,9,30,31]. The highest expression of PERV was 
reported in the thymus and lung from MPs [31], and in kidneys and thymus of LW animals [32]. In this 
study, highest expression was found in the lung from transgenic animals with a GL and MP 
background (thymus preparations were not available) (FLI Mariensee) (Fig. 1A) and in the spleen of 
non-transgenic GL animals (LMU Munich) (Fig. 1B). Disseminated or local infections may stimulate 
PERV expression as activation of retrovirus expression was often described after infections with other 
viruses [33,34] or Toxoplasma gondii [35]. Such infection may happen in different organs, e.g., in the 
lung or in the spleen. In addition, both groups lived in different breeding 
institutions. The lowest PERV expression was found in pancreatic islet cells throughout all animals 
(Fig. 1A), confirming previous reports [33, 36]. This could facilitate islet cell transplantation for the 
treatment of diabetes, which is supposed to be the first application of porcine cells [37]. 
 
Specific and sensitive assays were developed in the past years to screen for PERV infection, provirus 
distribution, and PERV expression, at the mRNA level and the protein level as well [8,9,38]. Here, 
these methods were applied to screen systematically for PERV distribution and expression in 
transgenic pigs generated for xenotransplantation research. Animals expressing hDAF and CD46 to 
overcome the HAR as well as TRAIL and HLA-E to control the cellular immune responses were 
analyzed for PERV expression (Table 7). Recently, transgenic pigs were generated expressing a 
PERV-specific short hairpin RNA, where PERV expression was efficiently inhibited by RNA 
interference [39]. It is anticipated that multi-transgenic animals will minimize the rejection of pig tissues 
and decrease the risk of PERV transmission. All these strategies will contribute to an optimized source 
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Fig. 1. (A) Expression of porcine 
endogenous retroviruses (PERV) in 
different tissues of multi-transgenic (TRAIL, 
CD55, CD59) German landrace (GL) pigs 
(#366) and GL pig · mini-pig (MP) animals 
(#374, #375) as measured by real time 
polymerase chain reaction. Expression in 
the lung was set 100%. (B) Expression of 
PERV in different tissues of fivedifferent 
non-transgenic GL pigs (1--5), expression 
in the spleen was set 100%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
